澳洋健康(002172.SZ)发布前三季度业绩，归母净利润4011.37万元，同比增长3.71%

Core Viewpoint - Aoyang Health (002172.SZ) reported a decline in revenue for the first three quarters of 2025, while net profit showed a slight increase, indicating mixed financial performance [1] Financial Performance - The company achieved an operating revenue of 1.36 billion yuan, representing a year-on-year decrease of 9.39% [1] - The net profit attributable to shareholders of the listed company was 40.11 million yuan, reflecting a year-on-year increase of 3.71% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 32.03 million yuan, which is a year-on-year decrease of 10.61% [1]